StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NYSE · TMO·Healthcare

Thermo Fisher Scientific Inc. Stock Analysis & AI Score

Thermo Fisher Scientific Inc. (TMO) has an ST Score of 49.6 (C+), driven by its Sentiment (A+) and held back by its Valuation (D-). Analysts rate it Buy with a $631.42 price target (-7.1% downside).

Market Closed
$679.61
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
50
ST Score
49.6/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date—
Website—
Country—
ExchangeNYSE

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

TMO
49.6out of 100
Grade C+

Thermo Fisher Scientific Inc. (TMO) has an ST Score of 49.6 (C+), driven by its Sentiment (A+) and held back by its Valuation (D-). Analysts rate it Buy with a $631.42 price target (-7.1% downside).

Strongest
SentimentA+
Weakest
ValuationD-
All factor grades
  • SentimentA+
  • ProfitabilityA
  • MomentumB
  • GrowthC
  • ForecastD+
  • Financial StrengthD
  • ValuationD-
  • Piotroski6/9
Score methodology
Press Releases

Contact

TMO stock: frequently asked questions

What is TMO's ST Score?

Thermo Fisher Scientific Inc. (TMO) has an ST Score of 49.6 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is TMO a buy, hold, or sell?

Analysts rate TMO a Buy, with a price target of $631.42 (-7.1% vs the current price). Our ST Score grades it C+ (49.6/100). The ST Score is a data-driven signal, not a recommendation.

What are TMO's factor grades?

Valuation D-, Profitability A, Financial Strength D, Momentum B, Growth C, Forecast D+, Sentiment A+.

What is TMO's valuation grade?

Thermo Fisher Scientific Inc. (TMO) earns a valuation grade of D-, measured against Medical - Diagnostics & Research peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is TMO's growth grade?

Thermo Fisher Scientific Inc. (TMO) earns a growth grade of C, measured against Medical - Diagnostics & Research peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is TMO's profitability grade?

Thermo Fisher Scientific Inc. (TMO) earns a profitability grade of A, measured against Medical - Diagnostics & Research peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is TMO's financial strength grade?

Thermo Fisher Scientific Inc. (TMO) earns a financial strength grade of D, measured against Medical - Diagnostics & Research peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for TMO?

The average analyst price target for Thermo Fisher Scientific Inc. (TMO) is $631.42 from 43 analysts, which is -7.1% versus the recent price of $679.61.

What is TMO's Piotroski score?

Thermo Fisher Scientific Inc. (TMO) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.